News features and technical articles about the evolution of aquaculture, one of the world’s fastest growing industries.


Error, no group ID set! Check your syntax!
Innovation & Investment

Aquaculture Exchange: Ron Stotish, AquaBounty Technologies

Ron Stotish, CEO of AquaBounty Technologies, discusses being the first to produce a genetically modified (GM) farmed salmon deemed safe for consumption, the controversy surrounding his company's product and the potential of biotechnology. 

Innovation & Investment

What investors see when they look at seafood

Investors see the good, bad and ugly aspects of the seafood industry. Experts at the IntraFish Seafood Investors Forum described the headwinds facing the market, like consumer confusion, while offering glimpses into their strategies (hint: patience is a virtue). 

Innovation & Investment

Investors see (mostly) upsides in aquaculture’s outlook

Aquaculture is attractive to investors, but they remain wary of diseases that could stunt projections of massive growth. At the IntraFish Seafood Investors Forum in New York, discussion about the salmon industry and its challenges — antibiotics, genetically modified fish, 


Science fact-checker debunks GM salmon criticisms

An article by concluded that fears regarding risk to human and environmental health posed by GM salmon are unfounded. Meanwhile, a group of environmental NGOs has sued the U.S. Food and Drug Administration over its approval of the fish 


GM salmon and the FDA: 10 takeaways

After a 20-year process, a genetically modified fish earned U.S. Food and Drug Administration approval, reigniting one of the seafood industry’s most intriguing controversies. Here are 10 key downloads from the groundbreaking decision over AquAdvantage salmon.